{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2024-07-22T00:00:00", "title": "AO 24-05", "url": "https://oig.hhs.gov/compliance/advisory-opinions/24-05/", "attachments": [{"title": "Advisory Opinion 24-05", "url": "https://oig.hhs.gov/documents/advisory-opinions/9936/AO-24-05.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-24-05", "subagency": "Office of the Inspector General", "summary": "Favorable in part and unfavorable in part opinion regarding proposed assistance for: (i) travel, lodging, meals, and associated expenses; and (ii) fertility preservation services for qualifying patients receiving one of two gene therapy treatments developed by a publicly traded biotechnology company."}